Meetings

  • Applying Big Data to Address the Social Determinants of Health in Oncology: A Workshop Date: October 28, 2019 - October 29, 2019 (8:00 AM Eastern)

    The collection and analysis of big data is expected to transform the field of cancer research and improve cancer care. Innovations in analytic methods, coupled with large-scale efforts to collect big data, are advancing progress in precision medicine initiatives and facilitating research on factors that influence cancer incidence and outcomes.
  • Exploring the Current Landscape of Consumer Genomics - A Workshop Date: October 29, 2019 (8:30 AM Eastern)

    The Roundtable on Genomics and Precision Health will host a one day public workshop on October 29, 2019 to explore the current landscape of consumer genomics and implications for how genetic test information is used or may be used in research and clinical care. Discussions may include topics such as diversity of participant populations, impact on health literacy and engagement, knowledge gaps related to use in clinical care, and data privacy/security concerns.
  • Understanding and Responding to Global Health Security Risks from Microbial Threats in the Arctic: A Workshop Date: November 6, 2019 - November 7, 2019 (12:00 AM GMT+2)

    This workshop will bring together an international, interdisciplinary group of experts to explore what is known, and what critical knowledge gaps remain, regarding existing and possible future risks of harmful infectious agents emerging from thawing Arctic environments
  • Workforce for Serious Illness Care: Challenges and Opportunities A Workshop Date: November 7, 2019 (8:30 AM Eastern)

    The Roundtable on Quality Care for People with Serious Illness will be holding a workshop on November 7, 2019 on the topic of the serious illness care workforce.
  • Exploring Novel Clinical Trial Designs for Gene-Based Therapies – A Workshop Date: November 13, 2019 (8:30 AM Eastern)

    Designing clinical trials to test the safety and efficacy of regenerative medicine therapies, such as gene- and gene-editing- based therapies, can be complex for several reasons including challenges with determining an optimal dosage, delivering the product effectively, and successfully recruiting patients, to name a few. Patients and clinicians may also face difficult decisions about enrollment in a gene therapy or trial in certain instances where the trial is considered to offer a “single chance,” possibly making the patients ineligible for future trials. To further explore the design complexities and ethical issues associated with clinical trials for these types of therapies, the Forum on Regenerative Medicine will hold a one-day workshop in Washington, DC on November 13, 2019. Speakers at the workshop may be asked to discuss patient recruitment and selection for gene-based clinical trials, assessing the safety of new therapies, dose escalation, and ethical issues such as informed consent and the role of clinicians in recommending trials as options to their patients.
  • Educating Health Professionals to Address the Social Determinants of Mental Health: A Workshop Date: November 14, 2019 - November 15, 2019 (9:00 AM Eastern)

    A planning committee will plan and conduct a 1.5-day public workshop to explore how health professions education and practice organizations and programs, are currently addressing social determinants that contribute to mental health disparities across the lifespan. The workshop will also set the stage for discussions on how disparities can affect the mental health and well-being of patients, families, communities, and care providers across the learning continuum. The planning committee will develop a workshop agenda, select and invite speakers and discussants, and moderate the discussions. Following the workshop, a proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
  • Sharing Clinical Trial Data: Reflecting Back and Looking Ahead – A Workshop Date: November 18, 2019 - November 19, 2019 (8:30 AM Eastern)

    An ad hoc planning committee under the auspices of the National Academies of Sciences, Engineering, and Medicine, will plan and conduct a two-day public workshop to discuss advances, challenges, and opportunities in clinical trial data sharing efforts since the release of the 2015 Institute of Medicine report, Sharing Clinical Trial Data: Maximizing Benefits, Minimizing Risk. This workshop is co-sponsored by the Wellcome Trust
  • Examining the State of the Science of Mammalian Embryo Model Systems: A Workshop Date: November 20, 2019 (8:30 AM Eastern)

    An ad hoc committee will plan and conduct a one day public workshop to explore the state of the science of mammalian embryo model systems, including nonhuman primate and human models. The goal of the workshop will be to begin with an overview of the developments and uses that have set the foundation for the field, then to focus in on opportunities and challenges for future work with embryo model systems. Discussions may include topics such as the characteristics of advanced mammalian embryo model systems; differences between mammalian embryo model systems and bona fide mammalian embryos; and differences between mammalian embryo model systems and mammalian embryoid bodies (i.e. culture systems in which pluripotent stem cells aggregate and differentiate, but are not intended to fully replicate embryonic development). The functionality of synthetic model systems may be considered, including how they could be used to predict function in systems made with human cells.
  • A Population Health Perspective on Middle School Success: Activities, Programs, and Policies: A Workshop Date: December 5, 2019 (8:00 AM Eastern)

    An ad hoc planning committee will organize and convene a one-day, interactive public workshop to explore the factors that affect the health and well-being of middle-school aged adolescents.